Urteste develops diagnostic tests for more than ten of the most common cancers (pancreatic, prostate, kidney, colorectal, liver, bile duct, breast, stomach, lung, throat, ovary, ovorian, non-hodgkin lymphoma, leukemia, glioma). The company’s key project is PANURI project, involving research on a test to detect pancreatic cancer. A research experiment involving humans hasbeen completed, confirming the high sensitivity and specificity of the test. Urteste’s second project is the MULTI-CANCER project, involving research on a test for simultaneous detection of multiple types of cancer.